Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00566722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00566722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
April 30, 2009
Enrollment
152 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis